For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Clinical conundrums surrounding medicine substitutions for people from abroad
+Practice
In print
PHARMACOTHERAPY
Clinical conundrums surrounding medicine substitutions for people from abroad
Wednesday 12 August 2020, 12:40 AM

Optimal treatment may not be available for people returning from overseas
Pharmacist prescriber Penny Clark uses a patient with well-controlled diabetes to illustrate the issues associated with people returning from overseas on medicines that are unavailable or unfunded in New Zealand
Key points, Patients returning from overseas on optimal, evidence-based medicines may need to change their prescriptions to those that are available or funded in , Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.